| Total (N = 292) | RF (N = 147) | CB (N = 145) | p-value RF vs. CB |
---|---|---|---|---|
Male gender | 176 (60.3) | 83 (56.5) | 93 (64.1) | 0.22 |
Age (years)†| 61.0 (54.8, 67.0) | 60.0 (55.0, 67.5) | 62.0 (54.0, 66.0) | 0.96‡ |
Comorbidities | ||||
 CAD | 37 (12.7) | 18 (12.2) | 19 (13.1) | 0.83†|
 Hypertension | 187 (64.0) | 95 (64.6) | 92 (63.4) | 0.93 |
 Diabetes | 28 (9.6) | 16 (10.9) | 12 (8.3) | 0.58 |
 Vascular disease | 15 (5.1) | 11 (7.5) | 4 (2.8) | 0.12 |
 Common ostium | 55 (18.8) | 35 (23.8) | 20 (13.8) | 0.04 |
Prior medication | ||||
 Phenprocoumon | 214 (73.3) | 108 (73.5) | 106 (73.1) | 1.00 |
 DOAC | 76 (26.0) | 37 (25.2) | 39 (26.9) | 0.84 |
 Platelet inhibitora | 34 (11.9) | 21 (14.7) | 13 (9.2) | 0.20 |
 Bridgingb | 40 (14.1) | 24 (16.9) | 16 (11.3) | 0.23 |